Cita APA (7a ed.)

Verderosa, A. D., Dhouib, R., Hong, Y., Anderson, T. K., Heras, B., & Totsika, M. (2021). A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Nature Portfolio.

Cita Chicago Style (17a ed.)

Verderosa, Anthony D., Rabeb Dhouib, Yaoqin Hong, Taylah K. Anderson, Begoña Heras, y Makrina Totsika. A High-throughput Cell-based Assay Pipeline for the Preclinical Development of Bacterial DsbA Inhibitors as Antivirulence Therapeutics. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Verderosa, Anthony D., et al. A High-throughput Cell-based Assay Pipeline for the Preclinical Development of Bacterial DsbA Inhibitors as Antivirulence Therapeutics. Nature Portfolio, 2021.